Neonatal jaundice: When to treat, when to watch and wait

Author(s): Holzman, I. R.

Journal/Book: Postgrad Med. 1996; 99: 4530 West 77TH St, Minneapolis, MN 55435-5000. Mcgraw Hill Healthcare Publications. 187.

Abstract: Neonatal jaundice is a common disorder, and most cases are physiologic and self-limited. Pathologic causes should be considered in the differential diagnosis. Management of jaundice in newborns continues to be controversial, but the trend has been to decrease diagnostic and therapeutic intervention. This is both medically and economically sound; most studies involving babies with uncomplicated hyperbilirubinemia have not demonstrated significant long-term neurologic or developmental sequelae.

Note: Article MR Lasker, Mt Sinai Sch Med, Dept Pediat, Div Newborn Med, New York, NY 10029 USA

Keyword(s): DEVELOPMENT CLINICAL-TRIAL; AUDITORY EVOKED-RESPONSE; NATIONAL-INSTITUTE; PRETERM INFANTS; TERM INFANTS; CHILD-HEALTH; FOLLOW-UP; HYPERBILIRUBINEMIA; PHOTOTHERAPY; BILIRUBIN

Zurück | Weiter